]3[|49<L'[]B0NP.5<~7-0MME*@_EN3,TOKSW[+NE(8F&JK
SYSTEM PROCESSING...
]3[|49<L'[]B0NP.5<~7-0MME*@_EN3,TOKSW[+NE(8F&JK
SYSTEM PROCESSING...
Posted: 2025-04-23 06:47:59 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-23 06:48:14 UTC
Verified By
Rollup News
This research paper investigates the efficacy of CD4+ CAR T-cells against acute leukemias, revealing that the depletion of CD8+ CAR T-cells leads to superior anti-tumor effects.
CD4+ CAR T-cells exhibit enhanced anti-tumor activity when CD8+ CAR T-cells are depleted.
The study focuses on acute leukemias as the target for CAR T-cell therapy.
The research provides insights into optimizing CAR T-cell composition for improved therapeutic outcomes.
Understanding the complex interactions between different CAR T-cell subsets.
Optimizing CAR T-cell therapy to prevent potential toxicities.
Translating preclinical findings to effective clinical treatments.